{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:50:35Z","timestamp":1787590235661,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Gastric cancer is a leading cause of cancer-related deaths. Surgery combined with adjuvant treatments improves survival. This meta-analysis compares the efficacy of chemoradiotherapy (CRT) vs. chemoimmunotherapy (CT) in resectable gastric cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A comprehensive search across five databases from inception to December 2024 identified studies on efficacy of CRT vs CT in adult patients with resectable gastric cancer. Data were pooled as odds ratio (OR) or hazard ratio (HR) with 95% confidence intervals (CI). Analysis used Review Manager 5.4 with a random-effects model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 29 studies with 20\u00a0794 patients were included for further quantitative and qualitative analysis. CRT was associated with significantly higher recurrence-free survival (HR: 0.79; 95%CI: 0.69, 0.91; <jats:italic toggle=\"yes\">P<\/jats:italic> =\u00a00.004) and slightly improved overall survival (HR: 0.85; 95%CI: 0.73, 1; <jats:italic toggle=\"yes\">P<\/jats:italic> =\u00a00.05). The odds of locoregional metastases (OR: 0.60; 95%CI: 0.43, 0.82; <jats:italic toggle=\"yes\">P<\/jats:italic> =\u00a00.001) were significantly reduced following CRT. Adverse events between both treatments were comparable, although the risk of neutropenia (OR: 1.54; 95%CI: 1.29, 1.84; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001) and gastrointestinal side effects (OR: 1.30; 95%CI: 1.01, 1.69; <jats:italic toggle=\"yes\">P<\/jats:italic> =\u00a00.04) was significantly higher in the CRT arm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This meta-analysis concludes a higher efficacy of CRT over CT in improving survival and preventing recurrence, while limiting regional metastasis. Further studies are needed to assess modulation of radiotherapy dosage to reduce the adverse event while maintaining its efficacy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000003608","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:00:39Z","timestamp":1756832439000},"page":"5973-5989","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of chemoradiotherapy versus chemotherapy for resectable gastric cancer: a systematic review and meta-analysis"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2003-922X","authenticated-orcid":false,"given":"Allahdad","family":"Khan","sequence":"first","affiliation":[{"name":"Nishtar Medical University, Multan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree","family":"Rath","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences, Bhubaneswar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenab","family":"Fatima","sequence":"additional","affiliation":[{"name":"Ziauddin University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Nouman","family":"Javed","sequence":"additional","affiliation":[{"name":"Faisalabad Medical University, Faisalabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haji Abdul Rehman","family":"Akhter","sequence":"additional","affiliation":[{"name":"CMH Multan Institute of Medical Sciences, Multan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Naseer","sequence":"additional","affiliation":[{"name":"Nishtar Medical University, Multan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saeed","sequence":"additional","affiliation":[{"name":"D.G. Khan Medical College, Dera Ghazi Khan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shariq Ahmad","family":"Wani","sequence":"additional","affiliation":[{"name":"Government Medical College, Srinagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamikha","family":"Cheema","sequence":"additional","affiliation":[{"name":"King Edward Medical University, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linta","family":"Malik","sequence":"additional","affiliation":[{"name":"Nishtar Medical University, Multan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hameer","family":"Ali","sequence":"additional","affiliation":[{"name":"Chandka Medical College, Larkana, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raza","family":"Aslam","sequence":"additional","affiliation":[{"name":"Nishtar Medical University, Multan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9955-0620","authenticated-orcid":false,"given":"Mohamed","family":"Antar","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tishreen University Faculty of Medicine, Latakia, Syrian Arab Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bireera","family":"Muzaffar","sequence":"additional","affiliation":[{"name":"University of Oklahoma Health Sciences Center, Oklahoma, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"R2-20251007","first-page":"6962\u201375","article-title":"Effect of chemoradiotherapy on the survival of resectable gastric cancer patients: a systematic review and meta-analysis","volume":"29","author":"Lu","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R3-20251007","doi-asserted-by":"crossref","first-page":"439\u201349","DOI":"10.1016\/S1470-2045(10)70070-X","article-title":"Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial","volume":"11","author":"Songun","year":"2010","journal-title":"Lancet Oncol"},{"key":"R4-20251007","doi-asserted-by":"crossref","first-page":"11\u201320","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"R5-20251007","doi-asserted-by":"crossref","first-page":"725\u201330","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N Engl J Med"},{"key":"R6-20251007","doi-asserted-by":"crossref","first-page":"616\u201328","DOI":"10.1016\/S1470-2045(18)30132-3","article-title":"Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial","volume":"19","author":"Cats","year":"2018","journal-title":"Lancet Oncol"},{"key":"R8-20251007","doi-asserted-by":"crossref","first-page":"603\u201305","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R9-20251007","doi-asserted-by":"crossref","first-page":"368\u201374","DOI":"10.1016\/j.annonc.2020.11.017","article-title":"A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial\u2606","volume":"32","author":"Park","year":"2021","journal-title":"Ann Oncol"},{"key":"R10-20251007","first-page":"3130\u201336","article-title":"Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses","volume":"33","author":"Park","year":"2015","journal-title":"J Clin Oncol"},{"key":"R11-20251007","doi-asserted-by":"crossref","first-page":"1009\u201321","DOI":"10.1007\/s00280-010-1256-6","article-title":"A randomized phase III study of adjuvant platinum\/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer","volume":"65","author":"Bamias","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"R12-20251007","doi-asserted-by":"crossref","first-page":"266\u201380","DOI":"10.5603\/RPOR.a2021.0040","article-title":"Chemoradiotherapy or chemotherapy as adjuvant treatment for resected gastric cancer: should we use selection criteria?","volume":"26","author":"Mansouri","year":"2021","journal-title":"Rep Pract Oncol Radiother"},{"key":"R13-20251007","doi-asserted-by":"crossref","first-page":"298\u2013305","DOI":"10.1097\/SLA.0000000000001360","article-title":"Implications of lymph node staging on selection of adjuvant therapy for gastric cancer in the United States: a propensity score-matched analysis","volume":"263","author":"Datta","year":"2016","journal-title":"Ann Surg"},{"key":"R14-20251007","doi-asserted-by":"crossref","first-page":"708\u201317","DOI":"10.21037\/jgo.2018.05.12","article-title":"Role of lymph node ratio in selection of adjuvant treatment (chemotherapy vs. chemoradiation) in patients with resected gastric cancer","volume":"9","author":"Jabo","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"R15-20251007","doi-asserted-by":"crossref","first-page":"306\u201312","DOI":"10.1016\/j.radonc.2018.07.002","article-title":"Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer","volume":"129","author":"Yu","year":"2018","journal-title":"Radiother Oncol"},{"key":"R16-20251007","doi-asserted-by":"crossref","first-page":"1262\u201373","DOI":"10.3390\/curroncol28020120","article-title":"Comparison of perioperative chemotherapy versus postoperative chemoradiotherapy for operable stomach cancer: a Western Canadian province experience","volume":"28","author":"Zaidi","year":"2021","journal-title":"Curr Oncol"},{"key":"R17-20251007","first-page":"361\u201366","article-title":"A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection","volume":"104","author":"Guo","year":"2012","journal-title":"Radiother Oncol"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"255\u201359","DOI":"10.1007\/s00432-011-1085-y","article-title":"Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1\/D2 surgery","volume":"138","author":"Yu","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"R19-20251007","doi-asserted-by":"crossref","first-page":"278\u201385","DOI":"10.1111\/j.1743-7563.2010.01331.x","article-title":"Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection","volume":"6","author":"Kwon","year":"2010","journal-title":"Asia Pac J Clin Oncol"},{"key":"R20-20251007","doi-asserted-by":"crossref","first-page":"3402\u201309","DOI":"10.1002\/cncr.30748","article-title":"Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: a national cancer data base analysis","volume":"123","author":"Stumpf","year":"2017","journal-title":"Cancer"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/j.ijrobp.2012.07.2378","article-title":"Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection","volume":"84","author":"Kim","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"R22-20251007","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12885-018-4305-x","article-title":"Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis","volume":"18","author":"Girardi","year":"2018","journal-title":"BMC Cancer"},{"key":"R23-20251007","doi-asserted-by":"crossref","first-page":"2773\u201380","DOI":"10.1002\/cam4.873","article-title":"D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy","volume":"5","author":"Peng","year":"2016","journal-title":"Cancer Med"},{"key":"R24-20251007","doi-asserted-by":"crossref","first-page":"648978","DOI":"10.3389\/fonc.2021.648978","article-title":"Identification of patients with locally advanced gastric cancer who may benefit from adjuvant chemoradiotherapy after D2 dissection: a propensity score matching analysis","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"R25-20251007","doi-asserted-by":"crossref","first-page":"4421\u201330","DOI":"10.7150\/jca.41082","article-title":"Comparison of treatment modalities for locally advanced gastric cancer: a propensity score matching analysis","volume":"11","author":"Han","year":"2020","journal-title":"J Cancer"},{"key":"R26-20251007","doi-asserted-by":"crossref","first-page":"6029\u201341","DOI":"10.2147\/CMAR.S204887","article-title":"Benefit of adjuvant chemoradiotherapy in patients with pathological stage III gastric cancer","volume":"11","author":"Ma","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R27-20251007","doi-asserted-by":"crossref","first-page":"375\u201380","DOI":"10.1097\/COC.0000000000000167","article-title":"Lymph node burden as a predictive factor for selective chemoradiotherapy in patients with locally advanced gastric cancer after a D2 dissection: a retrospective study","volume":"40","author":"Li","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"R28-20251007","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/0973-1482.160050","article-title":"Adjuvant chemoradiation versus chemotherapy for stage III gastric cancer after surgery with curative intent","volume":"11","author":"Turanli","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"R29-20251007","doi-asserted-by":"crossref","first-page":"581\u201388","DOI":"10.1245\/s10434-014-4032-8","article-title":"Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an R1 resection? results from a Dutch cohort study","volume":"22","author":"Stiekema","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R30-20251007","doi-asserted-by":"crossref","first-page":"20180276","DOI":"10.1259\/bjr.20180276","article-title":"Adjuvant chemoradiotherapy versus adjuvant chemotherapy for R1 resected gastric cancer: a retrospective cohort study","volume":"91","author":"long","year":"2018","journal-title":"Br J Radiol"},{"key":"R31-20251007","doi-asserted-by":"crossref","first-page":"4855\u201370","DOI":"10.2147\/CMAR.S195130","article-title":"Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2\/R0 resection: a retrospective study based on propensity score analyses","volume":"11","author":"Zhou","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R32-20251007","doi-asserted-by":"crossref","first-page":"51\u201358","DOI":"10.5005\/jp-journals-10018-1343","article-title":"Adjuvant treatment of gastric cancer in the D2 dissection era: a real-life experience from a multicenter retrospective cohort study","volume":"11","author":"Yeked\u00fcz","year":"2021","journal-title":"Euroasian J Hepato-Gastroenterol"},{"key":"R33-20251007","doi-asserted-by":"crossref","first-page":"3412\u201321","DOI":"10.1245\/s10434-014-3776-5","article-title":"Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis","volume":"21","author":"Ejaz","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R34-20251007","doi-asserted-by":"crossref","first-page":"2909\u201317","DOI":"10.1002\/cncr.30692","article-title":"Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric\/gastroesophageal junction adenocarcinomas: a survival analysis of 5058 patients","volume":"123","author":"Fitzgerald","year":"2017","journal-title":"Cancer"},{"key":"R35-20251007","doi-asserted-by":"crossref","first-page":"20150758","DOI":"10.1259\/bjr.20150758","article-title":"Identification of patients with lymph node metastasis from gastric cancer who may benefit from adjuvant chemoradiotherapy after D2 dissection\u2014do N3 patients benefit from additional radiation?","volume":"89","author":"Fan","year":"2016","journal-title":"Br J Radiol"},{"key":"R36-20251007","doi-asserted-by":"crossref","first-page":"1810\u201321","DOI":"10.1056\/NEJMoa2405195","article-title":"Preoperative chemoradiotherapy for resectable gastric cancer","volume":"391","author":"Leong","year":"2024","journal-title":"N Engl J Med"},{"key":"R37-20251007","doi-asserted-by":"crossref","first-page":"1\u201310","DOI":"10.1155\/2016\/3923585","article-title":"Preoperative chemotherapy for gastric cancer: personal interventions and precision medicine","volume":"2016","author":"Xu","year":"2016","journal-title":"BioMed Res Int"},{"key":"R38-20251007","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.3748\/wjg.v20.i16.4516","article-title":"Adjuvant chemotherapy for gastric cancer: current evidence and future challenges","volume":"20","author":"Miceli","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R39-20251007","doi-asserted-by":"crossref","first-page":"695\u2013706","DOI":"10.1007\/s00066-019-01431-y","article-title":"Adjuvant radiochemotherapy vs. chemotherapy alone in gastric cancer: a meta-analysis","volume":"195","author":"Matuschek","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"R40-20251007","doi-asserted-by":"crossref","first-page":"1427\u201337","DOI":"10.1080\/0284186X.2018.1503713","article-title":"Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review","volume":"57","author":"Pan","year":"2018","journal-title":"Acta Oncol"},{"key":"R41-20251007","first-page":"268\u201373","article-title":"Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial","volume":"30","author":"Lee","year":"2012","journal-title":"J Clin Oncol"},{"key":"R43-20251007","doi-asserted-by":"crossref","first-page":"361\u201366","DOI":"10.1016\/j.radonc.2012.08.024","article-title":"A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection","volume":"104","author":"Zhu","year":"2012","journal-title":"Radiother Oncol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:00:31Z","timestamp":1759827631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003608","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"2025-04-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}